NO160000C - Analogifremgangsm te for fremstilling av terapeutisk aktive forbindelser. - Google Patents

Analogifremgangsm te for fremstilling av terapeutisk aktive forbindelser.

Info

Publication number
NO160000C
NO160000C NO832659A NO832659A NO160000C NO 160000 C NO160000 C NO 160000C NO 832659 A NO832659 A NO 832659A NO 832659 A NO832659 A NO 832659A NO 160000 C NO160000 C NO 160000C
Authority
NO
Norway
Prior art keywords
preparation
active compounds
therapeutic active
analogy procedure
analogy
Prior art date
Application number
NO832659A
Other languages
English (en)
Other versions
NO832659L (no
NO160000B (no
Inventor
Howard Daniel Hollis Showalter
Judith L Johnson
Leslie M Werbel
Edward F Elslager
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US06/507,961 external-priority patent/US4556654A/en
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Publication of NO832659L publication Critical patent/NO832659L/no
Publication of NO160000B publication Critical patent/NO160000B/no
Publication of NO160000C publication Critical patent/NO160000C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09B—ORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES, e.g. PIGMENTS; MORDANTS; LAKES
    • C09B5/00—Dyes with an anthracene nucleus condensed with one or more heterocyclic rings with or without carbocyclic rings
    • C09B5/02—Dyes with an anthracene nucleus condensed with one or more heterocyclic rings with or without carbocyclic rings the heterocyclic ring being only condensed in peri position
    • C09B5/16—Benz-diazabenzanthrones, e.g. anthrapyrimidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C243/00—Compounds containing chains of nitrogen atoms singly-bound to each other, e.g. hydrazines, triazanes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/54—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/20—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof
    • C07D295/205—Radicals derived from carbonic acid

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO832659A 1982-07-23 1983-07-21 Analogifremgangsm te for fremstilling av terapeutisk aktive forbindelser. NO160000C (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US40115782A 1982-07-23 1982-07-23
US06/507,961 US4556654A (en) 1983-06-28 1983-06-28 Antimicrobial substituted anthra[1,9-cd]pyrazol-6(2H)-ones

Publications (3)

Publication Number Publication Date
NO832659L NO832659L (no) 1984-01-24
NO160000B NO160000B (no) 1988-11-21
NO160000C true NO160000C (no) 1989-03-01

Family

ID=27017319

Family Applications (1)

Application Number Title Priority Date Filing Date
NO832659A NO160000C (no) 1982-07-23 1983-07-21 Analogifremgangsm te for fremstilling av terapeutisk aktive forbindelser.

Country Status (18)

Country Link
EP (1) EP0103381B1 (no)
JP (2) JPH072719B2 (no)
KR (1) KR900005026B1 (no)
AR (1) AR240315A1 (no)
AU (1) AU549659B2 (no)
CA (1) CA1230115A (no)
DE (1) DE3373811D1 (no)
DK (3) DK159429C (no)
ES (3) ES8504731A1 (no)
FI (1) FI82932C (no)
GR (1) GR79610B (no)
HU (1) HU195779B (no)
IE (1) IE56782B1 (no)
IL (1) IL69211A (no)
NO (1) NO160000C (no)
NZ (1) NZ205001A (no)
PH (1) PH20906A (no)
PT (1) PT77088B (no)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1251450A (en) * 1984-06-29 1989-03-21 David B. Capps Benzopyrano¬4,3,2-cd|indazole compositions and methods for their production and use
CA1251451A (en) * 1984-06-29 1989-03-21 Ellen M. Berman Benzoseleno¬4,3,2-cd|indazole compositions and methods for their production and use
US4608439A (en) * 1985-04-26 1986-08-26 Warner-Lambert Company Process for preparing substituted anthra[1,9-cd]pyrazol-6(2H)-ones
US4672129A (en) * 1986-05-05 1987-06-09 Warner-Lambert Company Process for preparing substituted anthra[1,9-cd]pyrazol-6(2H)-ones
GB9107843D0 (en) * 1991-04-12 1991-05-29 Patterson Laurence H Anti-cancer compounds
GB9107852D0 (en) * 1991-04-12 1991-05-29 Patterson Laurence H Anti-cancer compounds
ATE200491T1 (de) * 1992-09-08 2001-04-15 Univ Vermont 2-aminoalkyl-5-aminoalkylamino substituierte isochinoindazole-6 (2h)-on mit antitumorwirkung
US5393886A (en) * 1993-05-05 1995-02-28 The Du Pont Merck Pharmaceutical Company Intermediates for the synthesis of anthrapyrazolone anticancer agents
US5596097A (en) * 1994-03-08 1997-01-21 The University Of Vermont Hetero-annulated indazoles
IT1277576B1 (it) * 1995-09-13 1997-11-11 Boehringer Mannheim Italia 2-2-(2-idrossietil) ammino etil -5- 2-metilammino etil ammino indazolo 4,3-gh isochinolin-6 (2h)-one come agente antitumorale
WO2008116161A2 (en) 2007-03-22 2008-09-25 The General Hospital Corporation Pyrazoloanthrone and derivatives thereof for the treatment of cancer expressing 'mullerian inhibiting substance' type ii receptor (misrii) and of excess androgen states

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH191142A (de) * 1936-02-07 1937-05-31 Chem Ind Basel Verfahren zur Herstellung eines Anthrachinonderivates.
GB470475A (en) * 1936-02-14 1937-08-16 Of Chemical Industry Soc Manufacture of dyestuffs and intermediate products
US2518150A (en) * 1946-02-01 1950-08-08 Ciba Ltd Vat dyestuffs
DE2558812A1 (de) * 1975-12-27 1977-07-07 Hoechst Ag Lichtempfindliche kopiermassen und darin enthaltene photoinitiatoren

Also Published As

Publication number Publication date
NO832659L (no) 1984-01-24
JPH072719B2 (ja) 1995-01-18
DK430289A (da) 1989-08-31
ES524380A0 (es) 1985-04-16
DK430389A (da) 1989-08-31
FI832638A (fi) 1984-01-24
DK159849C (da) 1991-05-13
JPS5951268A (ja) 1984-03-24
FI82932C (fi) 1991-05-10
DK159429C (da) 1991-03-18
DK159429B (da) 1990-10-15
ES529578A0 (es) 1985-09-01
FI832638A0 (fi) 1983-07-20
IL69211A (en) 1987-01-30
DK160251B (da) 1991-02-18
PT77088B (en) 1986-02-12
EP0103381A1 (en) 1984-03-21
AU549659B2 (en) 1986-02-06
DK329683A (da) 1984-01-24
DK159849B (da) 1990-12-17
DK329683D0 (da) 1983-07-18
DK160251C (da) 1991-07-22
ES8507503A1 (es) 1985-09-01
NZ205001A (en) 1986-09-10
IE831622L (en) 1984-01-23
GR79610B (no) 1984-10-31
DE3373811D1 (en) 1987-10-29
JPH07110829B2 (ja) 1995-11-29
CA1251442C (no) 1989-03-21
ES8507502A1 (es) 1985-09-01
DK430389D0 (da) 1989-08-31
EP0103381B1 (en) 1987-09-23
JPH07179389A (ja) 1995-07-18
IL69211A0 (en) 1983-11-30
KR900005026B1 (ko) 1990-07-18
KR840005431A (ko) 1984-11-12
CA1230115A (en) 1987-12-08
PH20906A (en) 1987-05-27
PT77088A (en) 1983-08-01
HU195779B (en) 1988-07-28
AR240315A1 (es) 1990-03-30
IE56782B1 (en) 1991-12-18
NO160000B (no) 1988-11-21
AU1681083A (en) 1984-01-26
DK430289D0 (da) 1989-08-31
ES529577A0 (es) 1985-09-01
FI82932B (fi) 1991-01-31
ES8504731A1 (es) 1985-04-16

Similar Documents

Publication Publication Date Title
NO158099C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive karbostyrilderivater.
NO160521C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 13alfa- alkylgonaner.
NO165838C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive substituerte trans-1,2-diamino-cykloheksylamidforbindelser.
NO160368C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive bicykliske azoforbindelser.
NO833705L (no) Fremgangsmaate for fremstilling av fenyl-piperidin-propanol-forbindelser.
NO166327C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive piperidinderivater.
NO156864C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive piperinderivater.
NO164835C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive karbostyril-derivater.
NO165239C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 1-benzyl-aminoalkyl-pyrrolidinon-derivater.
NO165192C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive glyserolderivater.
NO158060C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive kinolonforbindelser.
NO164168C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive 1,7,4-triazolforbindelser.
NO158183C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazolylfenylamidiner.
NO161679C (no) Analogifremgangsm te ved fremstilling av terapeutisk aktive steroider.
NO163693C (no) Fremgangsmaate for fremstilling av terapeutisk aktive forbindelser av platina.
NO161676C (no) Analogifremgangsm te til fremstilling av terapeutisk aktive mitosanderivater.
NO159654C (no) Analogifremgangsm te for fremstilling av terapeutisk aktive 2-guanidin-4-heteroaryltiazolderivater.
NO161562C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive ergolinderivater.
NO162155C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive vinylkarbonoksylsyrederivater.
NO165400C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive cefemforbindelser.
NO159528C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive aminoguanidinderivater.
NO160000C (no) Analogifremgangsm te for fremstilling av terapeutisk aktive forbindelser.
NO160079C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive cefem-derivater.
NO158941C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 4-piperidino-kinazolinderivater.
NO158739C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 2-piperazinopyrimidinderivater.

Legal Events

Date Code Title Description
MK1K Patent expired

Free format text: EXPIRED IN JULY 2003